Accelerate Diagnostics receives FDA marketing authorization for the Accelerate Pheno(TM)
Accelerate Diagnostics announced the FDA has granted the de novo request to market the Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit for identification and antibiotic susceptibility testing of pathogens directly from positive blood culture samples. February 24, 2017